inflammatory bowel disease
FDA Approves Risankizumab for Ulcerative Colitis
The FDA has approved risankizumab (Skyrizi, AbbVie) for patients with moderate to severe ulcerative colitis.
JULY 8, 2024
U.S. IBD Prevalence Is One of the Highest in the World
Nearly one in 100 people in the United States have a form of inflammatory bowel disease, according to a new study ...
NOVEMBER 14, 2023
Blimey! Scurvy Still Afflicts Some IBD Patients
When two of their patients with inflammatory bowel disease presented with some striking signs and symptoms, ...
JUNE 17, 2020
Epigenetics May Help Predict IBD Severity, Treatment
Epigenetic changes in newly diagnosed patients with inflammatory bowel disease may help determine which ones ...
JUNE 7, 2017
Study Finds Costs of Inpatient Inflammatory Bowel Disease Care ‘Mind-Boggling’
Total hospitalization charges for inpatient care of patients with inflammatory bowel disease (IBD) nearly doubled ...
FEBRUARY 22, 2017
Capsule Findings Can Profoundly Affect Patient Care
Honolulu—Capsule endoscopy can profoundly alter the clinical management of some patients with inflammatory ...
FEBRUARY 5, 2016